Dainippon Sumitomo Pharma America Inc. Announces FDA Acceptance of Lurasidone New Drug Application for Treatment of Schizophrenia
3/11/2010 11:54:41 AM
More...
|
Dainippon Sumitomo Pharma America Inc. Announces the NDA Submission of Lurasidone to the FDA for the Treatment of Schizophrenia
1/5/2010 8:38:01 AM
More...
|
Dainippon Sumitomo Pharma America Inc. Selects SAS(R) Solutions OnDemand: Drug Development to Manage Clinical Trial Data
11/2/2009 9:57:02 AM
More...
|
Dainippon Pharmaceutical, Sumitomo Pharmaceuticals Co. Ltd. And Ono Pharmaceutical Company, Ltd. To Enter Into Joint Development And Marketing Agreement For Limaprost Alfadex, Oral PGE1 Derivative
12/7/2005 11:48:57 AM
More...
|
Nipro Corporation To Purchase Dainippon Ink And Chemicals' Extracorporeal Membrane Oxygenation Business
10/19/2005 5:13:12 PM
More...
|
Dainippon Pharmaceutical , Eisai Company, Ltd. (ESALY.PK) Sign Licensing Agreement For Antiepileptic Agent Zonisamide
10/19/2005 5:13:10 PM
More...
|
Dainippon Pharmaceutical , Kowa Company Conclude Business Transfer Agreement
10/19/2005 5:13:07 PM
More...
|
Dainippon Pharmaceutical , ZOEGENE Corporation Conclude Joint Research Agreement In Diabetes And Obesity
10/19/2005 5:13:07 PM
More...
|
Dainippon Pharmaceutical And Kyorin Pharmaceutical Co., Ltd. To Collaborate In Development Of Drug Candidate For Diabetic Complication
10/19/2005 5:13:06 PM
More...
|
Kissei Pharmaceutical Co., Ltd., Dainippon Pharmaceutical Conclude Licensing Agreement For KGA-2727 Diabetes Drug Candidate
10/19/2005 5:13:03 PM
More...
|
|